Further, decreased ERRα expression on acute lapatinib treatment in vivo in the NIC tumours is concomitant with decreased mTOR signalling, while lapatinib-resistant tumours exhibit restoration of mTOR signalling along with the re-expression of high levels of ERRα (Fig. 2i). The gene discussed is ESRRA; the disease is neoplasm.